NCT05122143View on ClinicalTrials.gov

Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 10, 2021

Primary Completion Date

March 28, 2022

Study Completion Date

April 4, 2022

Conditions
Perennial Allergic RhinitisRhinitis, Allergic
Interventions
DEVICE

Treatment A

"Nasal Spray with drug-free aqueous gel emulsion (AM-301) intended to help protect against airborne allergens.~One Spray of AM-301 per nostril"

DEVICE

Treatment B

"Nasal Spray with drug-free aqueous gel emulsion (AM-301) intended to help protect against airborne allergens.~Two Sprays of AM-301 per nostril (with different spray angles)"

OTHER

Treatment C

No treatment

Trial Locations (1)

Unknown

Cliantha Research, Mississauga

Sponsors
All Listed Sponsors
lead

Altamira Medica Ltd.

INDUSTRY

NCT05122143 - Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers | Biotech Hunter | Biotech Hunter